Product image of Kenalog (Triamcinolone Acetonide) supplied by GNH India

Kenalog

Active Ingredient:
Triamcinolone Acetonide
Origin:
EU

Kenalog (Triamcinolone Acetonide)

Triamcinolone acetonide, the active ingredient in Kenalog, is a glucocorticoid presented as an injectable formulation for intraarticular, intralesional, and intramuscular use. It is employed to reduce inflammation and immune response in various musculoskeletal and dermatologic conditions.

GNH India supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kenalog (triamcinolone acetonide) is used in inflammatory and musculoskeletal disorders where glucocorticoid therapy is indicated.

  • Arthritis: reduces joint inflammation and pain, improving mobility.
  • Bursitis: diminishes bursal swelling and discomfort.
  • Tendonitis: alleviates tendon inflammation, facilitating functional recovery.
  • Dermatologic inflammatory conditions: suppresses skin inflammation such as eczema or psoriasis plaques.

How It Works

  • Triamcinolone acetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of immune and inflammatory responses.

Side Effects

Kenalog may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection‑site pain or tenderness.
  • Local bruising or swelling.
  • Transient elevation of blood glucose.
  • Mild skin thinning at the injection site.
  • Headache.

Serious or Rare Side Effects

  • Adrenal suppression or insufficiency.
  • Severe systemic infection or sepsis.
  • Anaphylactic or severe hypersensitivity reactions.
  • Vision changes, including cataracts or glaucoma.
  • Cushingoid appearance with prolonged high‑dose use.
  • Osteonecrosis of bone.

Precautions & Warnings

When prescribing Kenalog, clinicians should observe several safety considerations.

  • Infection risk: assess for active infections before injection.
  • Blood glucose monitoring: observe for hyperglycemia, especially in diabetic patients.
  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Dose minimization: use the lowest effective dose for the shortest duration.
  • Systemic fungal infection: avoid use in patients with uncontrolled systemic fungal disease.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Kenalog can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Live vaccines: concurrent use may suppress vaccine efficacy and increase infection risk.
  • Systemic CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic glucocorticoid levels, heightening adverse effects.
  • Anticoagulants (e.g., warfarin): glucocorticoids can enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

  • NSAIDs: combined use raises gastrointestinal ulcer risk.
  • Diuretics: may exacerbate hypokalemia caused by glucocorticoids.
  • Antidiabetic agents: glucocorticoid therapy may require dose adjustments to maintain glycemic control.

Frequently Asked Questions

Kenalog, containing triamcinolone acetonide, is indicated for inflammatory musculoskeletal disorders such as arthritis, bursitis and tendonitis, as well as for dermatologic inflammatory conditions where local glucocorticoid therapy is appropriate.

Triamcinolone acetonide binds to intracellular glucocorticoid receptors, altering gene transcription. This up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, resulting in reduced leukocyte migration, decreased capillary permeability, and overall suppression of inflammation and immune activity.

The dose of Kenalog is individualized by the prescribing clinician based on the specific indication, severity of disease, injection site, patient weight, and overall risk‑benefit assessment. No fixed regimen is provided here.

Safety data for triamcinolone acetonide in pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Kenalog, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Kenalog (triamcinolone acetonide) is a medium‑potency glucocorticoid often chosen for its strong anti‑inflammatory effect with a relatively favorable local tolerability profile compared with higher‑potency steroids. Choice among corticosteroids depends on potency, duration of action, injection site and physician preference.

Kenalog should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability.

Kenalog is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via intra‑articular, intralesional or intramuscular injection, depending on the targeted condition and therapeutic goal.

Serious risks include adrenal suppression, severe systemic infections, anaphylaxis, vision changes such as cataracts or glaucoma, Cushingoid features with prolonged high‑dose use, and osteonecrosis of bone. Prompt medical attention is required if any of these occur.

Kenalog is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any formulation component, and should be avoided in individuals with uncontrolled systemic fungal infections or active severe infections without appropriate antimicrobial coverage.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triamcinolone Acetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT